Trial Outcomes & Findings for The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System (NCT NCT05477602)

NCT ID: NCT05477602

Last Updated: 2026-01-30

Results Overview

Data collected during the study will be used to test an AF cycle length algorithm

Recruitment status

COMPLETED

Target enrollment

21 participants

Primary outcome timeframe

One day - day of procedure

Results posted on

2026-01-30

Participant Flow

Participant milestones

Participant milestones
Measure
Full Cohort
All patients recruited
Overall Study
STARTED
21
Overall Study
COMPLETED
21
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Full Cohort
n=21 Participants
All 21 patients in the PPT group
Age, Continuous
66.29 years
STANDARD_DEVIATION 9.12 • n=21 Participants
Sex: Female, Male
Female
9 Participants
n=21 Participants
Sex: Female, Male
Male
12 Participants
n=21 Participants
Weight
81.57 kg
STANDARD_DEVIATION 17.71 • n=21 Participants
Systolic Blood Pressure
138.48 mmHg
STANDARD_DEVIATION 21.18 • n=21 Participants
Diastolic Blood Pressure
86.33 mmHg
STANDARD_DEVIATION 12.59 • n=21 Participants
Heart Rate
78.9 BPM
STANDARD_DEVIATION 19.54 • n=21 Participants
Respiratory Rate
16.52 breaths/min
STANDARD_DEVIATION 2.62 • n=21 Participants

PRIMARY outcome

Timeframe: One day - day of procedure

Data collected during the study will be used to test an AF cycle length algorithm

Outcome measures

Outcome measures
Measure
Full Cohort
n=21 Participants
All enrolled patients
Measurement of AF Cycle Length
171.64 ms
Standard Deviation 27.23

Adverse Events

Full Cohort

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Full Cohort
n=21 participants at risk
All patients recruited
Vascular disorders
Bleeding from the groin
4.8%
1/21 • Enrollment until hospital discharge, up to 3 days

Other adverse events

Adverse event data not reported

Additional Information

Karl Firth

CathVision ApS

Phone: 0702097102

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place